These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 536969)

  • 21. [Treatment of hypertension using propranolol combined with hydralazine and a thiazidine diuretic. 1st results].
    Díaz de Losada JM
    Rev Clin Esp; 1975 Dec; 139(6):559-62. PubMed ID: 1215599
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of MRC (UK) trial of drug therapy for mild hypertension.
    Peart S
    Clin Invest Med; 1987 Nov; 10(6):616-20. PubMed ID: 3326701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the non-steroidal anti-inflammatory drugs, piroxicam or sulindac, on the antihypertensive actions of propranolol and verapamil.
    Baez MA; Alvarez CR; Weidler DJ
    J Hypertens Suppl; 1987 Dec; 5(5):S563-6. PubMed ID: 3481821
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension.
    Marshall AJ; Barritt DW; Pocock J; Heaton ST
    Lancet; 1977 Feb; 1(8006):271-4. PubMed ID: 64803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
    Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
    Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
    Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The management vf essential hypertension with once daily administration of timolol maleate and bendrofluazide.
    Deering RB; Fox AS; Ison LJ
    J Int Med Res; 1977; 5(2):114-9. PubMed ID: 326593
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A double-blind trial of captopril or bendrofluazide in newly diagnosed senile hypertension.
    Starr JM; Whalley LJ; Inch S; White A; Hadley L
    Curr Med Res Opin; 1994; 13(4):214-21. PubMed ID: 7882701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.
    Lancet; 1981 Sep; 2(8246):539-43. PubMed ID: 6115999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of atenolol, bendrofluazide, and hydrallazine to management of severe hypertension.
    Wilcox RG; Mitchell JR
    Br Med J; 1977 Aug; 2(6086):547-50. PubMed ID: 329948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bendrofluazide fails to reduce elevated blood pressure levels in the immediate post-stroke period.
    Eames PJ; Robinson TG; Panerai RB; Potter JF
    Cerebrovasc Dis; 2005; 19(4):253-9. PubMed ID: 15731556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind comparison between propranolol and bendroflumethiazide in captopril-treated resistant hypertensive patients.
    Staessen J; Fagard R; Lijnen P; Verschueren LJ; Amery A
    Am Heart J; 1983 Aug; 106(2):321-8. PubMed ID: 6346849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low dose bendrofluazide (1.25 mg) effectively lowers blood pressure over 24 h: results of a randomized, double-blind, placebo-controlled crossover study.
    Wiggam MI; Bell PM; Sheridan B; Walmsley A; Atkinson AB
    Am J Hypertens; 1999 May; 12(5):528-31. PubMed ID: 10342793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Verapamil and bendrofluazide in the treatment of hypertension: a controlled study of effectiveness alone and in combination.
    Benjamin N; Phillips RJ; Robinson BF
    Eur J Clin Pharmacol; 1988; 34(3):249-53. PubMed ID: 3294021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant effect of bendrofluazide on propranolol in hypertension.
    Mitchell I; Lodge R; Lawson AA
    Scott Med J; 1972 Oct; 17(10):326-9. PubMed ID: 4562883
    [No Abstract]   [Full Text] [Related]  

  • 39. Timolol and bendrofluazide in the management of hypertension in general practice.
    Wheatley D
    Eur J Clin Pharmacol; 1978 Dec; 14(5):319-24. PubMed ID: 365544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertension.
    Webster J; Dollery CT; Hensby CN
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():125s-128s. PubMed ID: 7004720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.